RxDoctor Payments Data

Russell Rowan, DPM

Podiatrist · Tallahassee, FLNPI 1578526612

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,165 of the $3,057 with a category attached, or 70.8%. 24 manufacturers reported payments, led by CGG Medical Inc at 38.4% of the total. Reporting peaked in 2019 at $975 and has fallen 81.7% since, to $179 in 2025.

$3,057in general payments, 2019–2025

Across 58 payments — averaging $52.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CGG Medical Inc$1K
  • Amgen$328
  • Smith+Nephew$201
  • Integra Lifesciences Corporation$200
  • Stryker$198
  • Convatec Inc.$175
  • plus $780 from 18 others

What the payments were for

  • Food & beverage$2,16571%
  • Education$89229%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,057 in reported general payments places this provider in the 70th percentile of 588 podiatrist providers in Florida.

See all podiatrist providers in Florida →

Medicare billing

Part B allowed, 2024
$98,263
Medicare patients
443
Services billed
1,186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole237$7,749
Ciclopirox49$1,699
Ammonium Lactate26$761
Mupirocin75$674
Meloxicam58$367
Doxycycline Hyclate28$342
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav24$259
Cephalexin30$172
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim24$162
Terbinafine Hcl16$132
Methylprednisolone15$127
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$66

Paid to pharmacies, not to this prescriber.

Other podiatrist in Tallahassee

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →